Defendant Name:
China Sky One Medical, Inc.
Defendant Type:
Public Company
SIC Code:
6700
CUSIP:
16941P10
Initial Case Details
Legal Case Name
SEC v. China Sky One Medical, Inc. and Yan-qing Liu
First Document Date
04-Sep-2012
Initial Filing Format
Civil Proceeding
Case Number
12-cv-07543
Allegation Type
Issuer Reporting and Disclosure
Federal District Court
California, Central District of California
Violations Alleged
•
Sec 17(a) (Not specified)
Additionally,
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Sec 13(a) of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Sec 13(a) of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Rule 13a-11 of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Rule 13a-11 of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Yan-Qing Lu is alleged to have aided and abetted China Sky One Medical, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act.
Yan-Qing Lu is alleged to have controlled China Sky One Medical, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act.
Resolutions
First Resolution Date
03-Mar-2015
Related Documents:
Complaint for Violations of the Federal Securities Laws
On September 4, 2012, the SEC filed a complaint against China Sky One Medical, Inc. and its Chairman, CEO and president, Yan-qing Liu. According to the complaint, "This is a financial fraud case involving the fabrication of export sales and material overstatement of financial results for 2007 and 2008...."
SEC Charges China Sky One Medical and Top Executive with Inflating Financial Results through Phony Sales
On September 4, 2012, the SEC issued a litigation release announcing that it charged China Sky One Medical, Inc. and its CEO and chairman "with fraud for recording fake sales of a weight loss product to inflate revenues in the company's financial statements by millions of dollars."
2012-175
04-Sep-2012
Press Release--Civil Action
SEC Charges China-Based Company and Top Executive with Inflating Financial Results through Phony Sales
On September 4, 2012, the SEC charged China Sky One Medical Inc. and its chief executive with fraud for recording fake sales of a weight loss product. The SEC alleges that China Sky One Medical falsely stated in 2007 annual and quarterly reports that it had entered into a strategic distribution scheme with a Malaysian company that would become an exclusive distributor of a product; the deal never took place.
Final Judgment of Permanent Injunction and Other Relief Against Defendants China Sky One Medical, Inc. and Yan-qing Liu
On March 3, 2015, Judge Michael W. Fitzgerald entered Final Judgment against China Sky One Medical, Inc. and Yan-qing Liu. The Final Judgment was pursuant to a motion by the SEC for Entry of Final Judgment by Default Against Defendants China Sky One Medical, Inc. and Yan-qing Liu.
Other Defendants in Action:
